drugset / Trial / NCT02475265

Transdermal Estrogen in Older Premenopausal Women With Anorexia Nervosa

NCT02475265

NaSingle-groupOpen-labelTreatment

Summary

Decreased bone strength is a common and serious medical problem present in many women with anorexia nervosa. Women with decreased bone strength are more likely to suffer broken bones than women with normal bone strength. This study will investigate whether the use of transdermal estrogen can improve bone mineral density (BMD) and bone microarchitecture in women with anorexia nervosa anorexia nervosa when used for 6 months.

Timeline

Start
2015-07
Primary completion
2018-06-27
Completion
2018-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 0.045 mg Other
Background Levonorgestrel Small molecule 0.015 mg Other